Downing Labs Recalls Magnesium Sulfate Injectable Due to Sterility Concerns
Downing Labs, LLC is recalling 160 vials of Magnesium Sulfate Injectable because the company cannot assure the sterility of the product.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II. Per the rubric, FDA Class II recalls are assigned a score of 4 (Severe), particularly when involving injectable products where sterility assurance is critical.
Plain-English summary
Downing Labs, LLC is recalling 160 vials of Magnesium Sulfate Injectable, 14.28%, 7mL vial, Rx only. The recall was initiated because the company lacks assurance of the sterility of the affected product. The recall covers all lots of this specific product.
The affected product was distributed nationwide in the US as well as to Australia, Brazil, the Bahamas, Switzerland, France, Colombia, Hong Kong, Indonesia, India, Japan, Malaysia, New Zealand, the Philippines, Singapore, Thailand, Trinidad and Tobago, and Taiwan. The FDA has classified this recall as Class II, indicating that use of, or exposure to, the violative product may cause temporary or medically reversible adverse health consequences.
Healthcare providers and patients should stop using the recalled product and contact Downing Labs, LLC at 1-800-914-7435 for further instructions regarding the return or disposal of the vials.
The recalled product
- Product
- Magnesium Sulfate Injectable, 14.28%, 7mL vial, Rx only, Downing Labs, LLC 4001 McEwen Rd, Suite 110, Dallas TX, 754244, 1-800-914-7435
- Manufacturer
- Downing Labs, LLC
- Category
- Drug — Injectable
- Hazard
- Affected units
- 160
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All lots
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 48 recalled by Downing Labs, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 48 products in this recall →Related recalls
Same manufacturer · Downing Labs, LLC
See all →- SevereDowning Labs Recalls Ascorbic Acid Injectable Due to Sterility Concerns
FDA (Drugs) · 2015-11-25
- SevereDowning Labs Recalls L-Glutathione Injection Due to Sterility Concerns
FDA (Drugs) · 2015-11-25
- SevereDowning Labs Recalls HCG Injectable Due to Sterility Assurance Concerns
FDA (Drugs) · 2015-11-25
- SevereDowning Labs Recalls Chromium Injectable Due to Sterility Assurance Concerns
FDA (Drugs) · 2015-11-25
- SevereDowning Labs Recalls L-Arginine Injection Due to Sterility Concerns
FDA (Drugs) · 2015-11-25
Same hazard · sterility
See all →- SevereK.C. Pharmaceuticals Recalls Target Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tri-MIX Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Semaglutide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tirzepatide Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Leader Advanced Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
Similar recalls
- SevereMagnesium Sulfate Injectable Recalled Due to Sterility Assurance Concerns
FDA (Drugs) · 2015-09-23
- SevereMagnesium Sulfate Injection Recalled Due to Sterility Assurance Concerns
FDA (Drugs) · 2014-01-22
- SevereGreen Valley Drugs Recalls Magnesium Sulfate Injection Due to Sterility Concerns
FDA (Drugs) · 2013-05-22
- SevereGuardian Pharmacy Recalls Magnesium Sulfate Vials Due to Sterility Concerns
FDA (Drugs) · 2018-08-15
- SevereRed Mountain Compounding Recalls Magnesium Sulfate Injection Due to Sterility Concerns
FDA (Drugs) · 2019-11-13
- SevereKey Pharmacy Recalls Magnesium Sulfate Injections Due to Sterility Concerns
FDA (Drugs) · 2017-05-24